Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Task marked complete
Friday's To Do's 
  •  Midi:
  •  digest, gel:
  •  transform TRE:Syk-15-tTEVp golden gate
Thursday's To Do's
  •  gel verify:
  •  Pick colonies for midi
  •  PCR purify TRE:Syk-15-tTEVp
  •  Golden gate TRE:Syk-15-tTEVp
  •  LR - probably can't do today because no LR clonase
    •  EGSH:mKate
    •  hEf1a:VgEcR-2A-RXR
    •  TRE:mKate
    •  hEF1a:Gal4VP16 (remember which pDEST)
    •  hEF1a:CD79B-TCS-Gal4VP16 
Wednesday's To Do's
  •  Flow cytometry with Brian (big grin)
  •  Order chicken lysozyme and gp120?
  •  Non-lab to do's
      •  Design (or find?) sequencing primers for mIgM CH (constant region)
      •  Plan experiment to test gantenerumab binding to beta-amyloid
      •  Leader sequences for ordering gBlocks of variable regions?

CMV5-CuO 715:

hEF1a-CuO 715:09

CymR-CuO 710:09


Geneious To Do List:
  •  Antibody cloning for chicken lysozyme - Kathryn 
  •  hef1a sequencing primers

 

BCR 2.0 To Do

^^^Email: bcrpeeps@mit.edu

^^^Pass: grapefruit

 

 

Higher Level To Do's:
  •  Decide on other antigen-variable regions we want to test  
  •  Other experimental planning (on experimental page)
  •  Parts list (excel sheet detailing specs/locations of parts)
  •  How do we do site directed mutagenesis?
  •  Literature research: 
    •  kozak sequences for heavy and light chains and CD79s
    •  truncated TEVp
    •  other antigens to detect using BCR (we were thinking of small molecule detection)
    •  inducible promoters (we were considering LacI - an inducible repressor - but we want to look into other options first) 
  •  Cloning planning 
    •  hEF1a:Syk-pTet:mRFP-TEVp
    •  variable region 
  •  Is gantenerumab proprietary and can we actually publish with it?